Page last updated: 2024-11-08

bicyclo(3,2,0)hept-2-en-6-one

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bicyclo(3,2,0)hept-2-en-6-one: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID297183
SCHEMBL ID460494
MeSH IDM0446920

Synonyms (28)

Synonym
bicyclo(3,2,0)hept-2-en-6-one
nsc167981
13173-09-6
nsc-167981
FT-0658162
AKOS009157067
(+/-)-cis-bicyclo[3.2.0]hept-2-en-6-one
bicyclo[3.2.0]hept-2-en-6-one
(+)-(1r,5s)-cis-bicyclo[3.2.0]hept-2-en-6-one
(1s,5s)-bicyclo[3.2.0]hept-2-en-6-one
J-500029
J-500491
bicyclo[3,2,0]hept-2-ene-6-one
SCHEMBL460494
cis-bicyclo[3.2.0]hept-2-en-6-one
CS-W008501
mfcd00066201
DTXSID10304884
bicyclo(3.2.0)hept-2-en-6-one,96%
J-006043
FT-0774176
FT-0773750
DS-11250
BCP29390
(+)-(1r,5s)-cis-bicyclo[3.2.0]hept-2-en-6-one pound>>(1r,5s)-bicyclo[3.2.0]hept-2-en-6-one
SY056869
SB45615
SB45491
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (83.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.20

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.20 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.28 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.20)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]